Northern Trust’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $766K | Buy |
392,716
+328,705
| +514% | +$641K | ﹤0.01% | 3509 |
|
2025
Q1 | $140K | Hold |
64,011
| – | – | ﹤0.01% | 4036 |
|
2024
Q4 | $208K | Buy |
+64,011
| New | +$208K | ﹤0.01% | 3978 |
|
2023
Q2 | – | Sell |
-4,812
| Closed | -$19K | – | 4558 |
|
2023
Q1 | $19K | Hold |
4,812
| – | – | ﹤0.01% | 4457 |
|
2022
Q4 | $14.4K | Hold |
4,812
| – | – | ﹤0.01% | 4535 |
|
2022
Q3 | $26K | Hold |
4,812
| – | – | ﹤0.01% | 4497 |
|
2022
Q2 | $21K | Hold |
4,812
| – | – | ﹤0.01% | 4616 |
|
2022
Q1 | $43K | Hold |
4,812
| – | – | ﹤0.01% | 4562 |
|
2021
Q4 | $42K | Buy |
4,812
+2,193
| +84% | +$19.1K | ﹤0.01% | 4618 |
|
2021
Q3 | $30K | Buy |
+2,619
| New | +$30K | ﹤0.01% | 4590 |
|